Progesterone: Dosing And Protocols

Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

**Progesterone**, a naturally occurring steroid hormone, is indispensable for numerous physiological processes, most notably in the female reproductive syste...

Progesterone, a naturally occurring steroid hormone, is indispensable for numerous physiological processes, most notably in the female reproductive system. It plays a critical role in regulating the menstrual cycle, preparing the uterus for pregnancy, and maintaining a healthy gestation. Beyond reproduction, progesterone contributes to bone health, neurological function, and overall well-being. Due to its diverse and vital functions, exogenous progesterone is widely utilized in clinical practice to address a range of conditions, from infertility and recurrent miscarriage to menopausal symptom management. However, the efficacy and safety of progesterone therapy are highly dependent on appropriate dosing, formulation, and adherence to specific protocols. These protocols vary significantly based on the indication, route of administration, and individual patient needs. This article aims to provide a comprehensive guide to the dosing and administration protocols for progesterone across its key clinical applications, emphasizing the importance of individualized treatment plans, careful monitoring, and patient education to optimize therapeutic outcomes and minimize potential side effects.

What Is Progesterone?

Progesterone is an endogenous steroid hormone belonging to the progestogen class, primarily synthesized by the corpus luteum in the ovaries and by the placenta during pregnancy. It is crucial for the regulation of the menstrual cycle and the establishment and maintenance of pregnancy. In clinical settings, bioidentical progesterone refers to formulations that are chemically identical to the hormone produced by the human body, often micronized for improved oral absorption. It is distinct from progestins, which are synthetic compounds designed to mimic some of progesterone's actions but may have different pharmacological properties and side effect profiles. Progesterone's primary physiological role is to prepare the endometrium for embryo implantation and to maintain pregnancy. Its broader actions include neuroprotective effects, modulation of mood, and contributions to bone mineral density.

How It Works

Progesterone exerts its diverse physiological effects by binding to specific intracellular progesterone receptors (PRs), which are members of the steroid hormone receptor superfamily. These receptors are widely distributed throughout the body, including the uterus, ovaries, breasts, brain, and bone. Upon binding, the progesterone-receptor complex undergoes a conformational change, translocates to the nucleus, and binds to specific DNA sequences known as progesterone response elements (PREs). This interaction modulates gene transcription, leading to the synthesis of specific proteins that mediate progesterone's biological actions.

In the female reproductive system, progesterone's primary actions include:

Endometrial Preparation: After ovulation, progesterone transforms the estrogen-primed proliferative endometrium into a secretory endometrium, making it receptive to embryo implantation. It promotes glandular secretion, stromal decidualization, and reduces uterine contractility.

Pregnancy Maintenance: During pregnancy, high levels of progesterone, initially from the corpus luteum and later from the placenta, are crucial. It maintains uterine quiescence by inhibiting myometrial contractions, prevents immunological rejection of the fetus, and supports the growth and development of the embryo and fetus.

Menstrual Cycle Regulation: Progesterone's cyclical rise and fall regulate the timing of menstruation. A drop in progesterone levels at the end of the luteal phase triggers the shedding of the endometrial lining.

Luteal Phase Support in ART: Numerous studies and clinical guidelines support the use of progesterone for luteal phase support in Assisted Reproductive Technologies (ART). Evidence indicates that adequate progesterone levels are crucial for endometrial receptivity and successful implantation. Various formulations and routes of administration (vaginal, oral, intramuscular) have been shown to be effective, with individualized protocols based on patient response and clinic preferences Devine et al., 2017.

Prevention of Preterm Birth: Large-scale randomized controlled trials have demonstrated the efficacy of progesterone in reducing the risk of preterm birth in specific high-risk populations. For instance, vaginal progesterone (200 mg daily) has been shown to be effective in women with a history of spontaneous preterm birth or a short cervix Dodd et al., 2013. The 17-alpha hydroxyprogesterone caproate (17P) injection (250 mg weekly) is also recommended for women with a history of spontaneous preterm birth.

Recurrent Miscarriage: While the evidence for progesterone in recurrent miscarriage has been evolving, recent trials suggest a benefit in certain subgroups. The PRISM trial, for example, indicated a potential benefit in women with a history of recurrent miscarriage and early pregnancy bleeding Coomarasamy et al., 2019.

Menopausal Hormone Therapy (MHT):

Endometrial Protection: The necessity of progesterone in MHT for women with an intact uterus is well-established. Clinical studies, including the Women's Health Initiative (WHI), have shown that combined estrogen-progestin therapy significantly reduces the risk of estrogen-induced endometrial hyperplasia and cancer compared to unopposed estrogen Writing Group for the Women's Health Initiative Investigators, 2002. Different dosing regimens (cyclic vs. continuous) have been developed to balance endometrial protection with patient preferences for bleeding patterns.

Vaginal Progesterone: Commonly prescribed as 100-200 mg two to three times daily (e.g., suppositories, gels, or inserts). Administration typically begins after oocyte retrieval or ovulation and continues until 8-12 weeks of gestation, or as directed by the fertility specialist. This route provides high local concentrations in the uterus.

Oral Micronized Progesterone: Doses typically range from 200-400 mg once daily, usually taken at bedtime. This route is also initiated after oocyte retrieval and continued through early pregnancy. The bedtime administration helps mitigate drowsiness.

Intramuscular Progesterone: 50-100 mg daily of progesterone in oil. This route provides consistent systemic levels and is often used in cases of vaginal intolerance or malabsorption, though it is less common due to patient discomfort.

For Prevention of Preterm Birth:

Vaginal Progesterone: 200 mg daily (suppository or gel) is typically administered from approximately 16-20 weeks of gestation until 34-36 weeks of gestation. This is recommended for women with a history of spontaneous preterm birth or a short cervix.

17-alpha Hydroxyprogesterone Caproate (17P) Injection: 250 mg intramuscularly once weekly from 16-20 weeks until 36 weeks of gestation. This is specifically for women with a history of spontaneous preterm birth.

For Menopausal Hormone Therapy (with Estrogen):

Oral Micronized Progesterone:

Cyclic Regimen: 200 mg daily for 12-14 consecutive days per 28-day cycle. This regimen is designed to induce a monthly withdrawal bleed, mimicking a natural menstrual cycle, and is suitable for women who prefer periodic bleeding.

Continuous Combined Regimen: 100 mg daily continuously. This aims to achieve amenorrhea (no bleeding) in most women, providing continuous endometrial protection. This is often preferred by women who wish to avoid monthly bleeding.

Transdermal Progesterone: Dosing varies by product and is typically applied daily as a cream or gel. This route may offer a more localized effect and bypass first-pass liver metabolism.

For Menstrual Irregularities/Endometriosis:

Dosing is highly individualized. It often involves cyclic oral progesterone (e.g., 10-20 mg of medroxyprogesterone acetate or 200 mg micronized progesterone for 10-14 days per cycle) to regulate bleeding, induce withdrawal bleeds, or suppress endometrial growth.

Adherence: Consistent and timely administration is crucial for achieving the desired therapeutic effects and minimizing risks. Missing doses can compromise treatment efficacy.